Comparative population pharmacokinetics of fentanyl using non-linear mixed effect modeling: Burns vs. non-burns

Burns

Volumn 35, Issue 6, 2009, Pages 790-797

  Kaneda, Kotaro ^a   Han, Tae Hyung ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Burns; Fentanyl; Non linear mixed effect model; Population pharmacokinetics

Indexed keywords

FENTANYL;

ADULT; ANALGESIC ACTIVITY; ARTICLE; BODY SURFACE; BURN; BURN PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; FEMALE; HEART INDEX; HUMAN; MALE; SINGLE DRUG DOSE;

ADULT; ANALGESICS, OPIOID; BURNS; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; TRAUMA SEVERITY INDICES; YOUNG ADULT;

EID: 67651067598     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2008.12.006     Document Type: Article

References (23)

1. Herndon D.N., and Tompkins R.G. Support of the metabolic response to burn injury. Lancet 5 (2004) 1895-1902
2. Jaehde U., and Sorgel F. Clinical pharmacokinetics in patients with burns. Clin Pharmacokinet 29 (1995) 15-28
3. Jeschke M.Q., Boehning D.F., Finnerty C.C., and Herndon D.N. Effect of insulin on the inflammatory and acute phase response after burn injury. Crit Care Med 35 (2007) S519-S523
4. Bjorkman S., Wada D.R., and Stanski D.R. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Anesthesiology 88 (1998) 657-667
5. Han T., Harmatz J.S., Greenblatt D.J., and Martyn J.A. Fentanyl clearance and volume of distribution are increased in patients with major burns. J Clin Pharmacol 47 (2007) 674-680
6. Kim K., Kwok I., Chang H., and Han T. Comparison of cardiac outputs of major burn patients undergoing extensive early escharectomy: esophageal Doppler monitor versus thermodilution pulmonary artery catheter. J Trauma 57 (2004) 1013-1017
7. Day J., Slawson M., Lugo R.A., and Wilkins D. Analysis of fentanyl and norfentanyl in human plasma by liquid chromatography-tandem mass spectrometry using electrospray ionization. J Anal Toxicol 27 (2003) 513-516
8. Naidong W., Bu H., Chen Y.L., Shou W.Z., Jiang X., and Halls T.D. Simultaneous development of six LC-MS-MS methods for the determination of multiple analytes in human plasma. Pharm Biomed Anal 28 (2002) 1115-1126
9. Sheiner B.L., and Beal S.L. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J Pharmacokinet Biopharm 9 (1981) 635-651
10. Wahlby U., Jonsson E.N., and Karlsson M.O. Assessment of actual significance levels for covariate effects in NONMEM. J Pharmacokinet Pharmacodyn 28 (2001) 231-252
11. Glatting G., Kletting P., Reske S.N., Hohl K., and Ring C. Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. Med Phys 34 (2007) 4285-4292
12. Parke J., Holford N.H.G., and Charles B.C. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effect population models. Comput Methods Programs Biomed 59 (1999) 19-29
13. McClain D.A., and Hug Jr. C.C. Intravenous fentanyl kinetics. Clin Pharmacol Ther 28 (1980) 106-114
14. Scott J.C., and Stanski D.R. Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmaeodynamic evaluation. J Pharmacol Exp Ther 240 (1987) 159-166
15. Shafer S.L., Varvel J.R., Aziz N., and Scott J.C. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 73 (1990) 1091-1102
16. Varvel J.R., Donoho D.L., and Shafer S.L. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 20 (1992) 63-94
17. Linneman P.K., Terry B.E., and Burd R.S. The efficacy and safety of fentanyl for the management of severe procedural pain in patients with burn injuries. J Burn Care Rehabil 21 (2000) 519-522
18. Perreault S., Choiniere M., du Souich P.B., Bellavance F., and Beauregard G. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries. Ann Pharmacother 35 (2001) 1588-1592
19. Summer G.J., Dina O.A., and Levine J.D. Enhanced inflammatory hyperalgesia after recovery from burn injury. Burns 33 (2007) 1021-1026
20. Singleton M.A., Rosen J.I., and Fisher D.M. Pharmacokinetics of fentanyl in the elderly. Br JAnaesth 60 (1988) 619-622
21. Shibutani K., Inchiosa Jr. M.A., Sawada K., and Bairamian M. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight ("pharmacokinetic mass"). Anesthesiology 101 (2004) 603-613
22. Davies G., Kingswood C., and Street M. Pharmacokinetics of opioids in renal dysfunction. Clin Pharmacokinet 31 (1996) 410-422
23. Kostopanagiotou G., Markantonis S.L., Arkadopoulos N., Andreadou I., Charalambidis G., Chondroudaki J., et al. The effect of acutely induced hepatic failure on remifentanil and fentanyl blood levels in a pig model. Eur J Anaesthesiol 23 (2006) 598-604